Drug Shortage Report for MAR-GABAPENTIN
Report ID | 81130 |
Drug Identification Number | 02391473 |
Brand name | MAR-GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 500 TABLET |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-04-10 |
Actual start date | 2019-04-10 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-04-11 |
Company comments | Demand is low, not ordered in recent months |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-04-11 | English | Compare |
v2 | 2019-04-10 | French | Compare |
v1 | 2019-04-10 | English | Compare |
Showing 1 to 3 of 3